Материал: part03

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

Page 1496​

DICOM PS3.3 2020a - Information Object Definitions​

Attribute Name​

Tag​

Attribute Description​

Product Expiration DateTime​

(0044,000B)​

The date and time after which the manufacturer no longer ensures the​

 

 

safety, quality, and/or proper functioning of the material.​

Product Parameter Sequence​

(0044,0013)​

Parameters of the product.​

 

 

Zero or more Items shall be included in this Sequence.​

>Include Table 10-2 “Content Item Macro Attributes​

Fordrugsorcontrastagents,forConceptNameCodeSequence,Baseline​

Description”​

 

CID 4050 “Drug or Contrast Agent Characteristics”​

 

 

For devices, for Concept Name Code Sequence, Baseline CID 3423​

 

 

“Numeric Device Characteristics”​

PertinentDocumentsSequence​

(0038,0100)​

Reference to a Product Label document for the product.​

 

 

Zero or more Items shall be included in this Sequence.​

>Referenced SOP Class UID​

(0008,1150)​

Unique identifier for the class of an HL7 Structured Product Label​

 

 

document.​

>ReferencedSOPInstanceUID​

(0008,1155)​

Unique identifier for the HL7 Structured Product Label Document as used​

 

 

in DICOM instance references (see Section C.12.1.1.6)​

>HL7 Instance Identifier​

(0040,E001)​

Instance Identifier of the referenced HL7 Structured Document, encoded​

 

 

as a UID (OID or UUID), concatenated with a caret ("^") and Extension​

 

 

value (if Extension is present in Instance Identifier).​

>Retrieve URI​

(0040,E010)​

Retrieval access path to Product Label Document. Includes fully specified​

scheme, authority, path, and query in accordance with [RFC3986]​ Note​

The VR of this Data Element has changed from UT to UR.​

C.26.2 Substance Approval Module​

Table C.26-2 specifies the Attributes used to approve the administration of a contrast agent, drug, or device to a patient.​

Table C.26-2. Substance Approval Module Attributes​

Attribute Name​

Tag​

Attribute Description​

Substance Administration​

(0044,0002)​ Status of request for substance administration.​

Approval​

Enumerated Values:​

 

 

 

 

APPROVED​

Use of the substance for the patient is approved, with​

 

 

related notes (e.g., appropriate dose for age/weight)​

 

 

in Approval Status Further Description (0044,0003)​

 

WARNING​

The substance may be used for the patient subject to​

 

 

warnings described in Approval Status Further​

 

 

Description (0044,0003)​

 

CONTRA_INDICATED​The substance should not be used for the patient for​

 

 

the reasons described in Approval Status Further​

 

 

Description (0044,0003)​

Approval Status Further​

(0044,0003)​ Description of warning or contra-indication, or notes on approval.​

Description​

 

 

Approval Status DateTime​

(0044,0004)​ Timestamp for the Substance Administration Approval response​

C.26.3 Substance Administration Module​

Table C.26-3 specifies the Attributes used to describe the act of administration of a contrast agent, drug, or device to a patient.​

- Standard -​

DICOM PS3.3 2020a - Information Object Definitions​ Page 1497​

Table C.26-3. Substance Administration Module Attributes​

Attribute Name​

Tag​

Attribute Description​

Administration Route Code Sequence​

(0054,0302)​

Route of administration for drug or contrast.​

 

 

Only a single Item shall be included in this Sequence.​

>Include Table 8.8-1 “Code Sequence Macro Attributes”​

BCID 11 “Route of Administration”.​

C.26.4 Substance Administration Log Module​

Table C.26-4 specifies the Attributes used to record the act of administration of a contrast agent, drug, or device to a patient.​

Table C.26-4. Substance Administration Log Module Attributes​

Attribute Name​

Tag​

Attribute Description​

Patient's Name​

(0010,0010)​

Patient's full name​

Patient ID​

(0010,0020)​

Primary identification number or code for the patient.​

Include Table 10-18 “Issuer of Patient ID Macro Attributes”​

 

Admission ID​

(0038,0010)​

Identification number of the Visit as assigned by the healthcare​

 

 

provider​

Issuer of Admission ID Sequence​

(0038,0014)​

Identifier of the Assigning Authority that issued the Admission ID.​

 

 

Only a single Item shall be included in this Sequence.​

>Include Table 10-17 “HL7v2 Hierarchic Designator Macro​

 

Attributes”​

 

 

Product Package Identifier​

(0044,0001)​

Identifierofthecontrastagent,drug,ordeviceadministered,typically​

 

 

from a package bar code, RFID, or other materials management​

 

 

ID.ThisIDmightnotbegloballyuniqueandmightconflictwithother​

 

 

IDs used within the scope of the institution.​

Product Name​

(0044,0008)​

Trade or generic name of product.​

 

 

Note​

 

 

May be multi-valued.​

Product Description​

(0044,0009)​

Textdescriptionofthecontrastagent,drug,ordeviceadministered.​

SubstanceAdministrationDateTime​

(0044,0010)​

Date and Time of Substance Administration​

Substance Administration Notes​

(0044,0011)​

Comments provided by the operator responsible for the substance​

 

 

administration.​

SubstanceAdministrationDeviceID​

(0044,0012)​

Identifier for a device that controls substance administration, e.g.,​

 

 

injector, infusion pump, etc.​

Administration Route Code​

(0054,0302)​

Route of administration for drug or contrast.​

Sequence​

 

Only a single Item shall be included in this Sequence.​

 

 

>Include Table 8.8-1 “Code Sequence Macro Attributes”​

BCID 11 “Route of Administration”.​

SubstanceAdministrationParameter​

(0044,0019)​

Parameters of the substance as administered to the patient, e.g.,​

Sequence​

 

volume, quantity.​

Zero or more Items shall be included in this Sequence.​

>Include Table 10-2 “Content Item Macro Attributes Description”​For administration of drugs or contrast agents, Baseline Context​ Group for Concept Name Code Sequence is CID 3410 “Numeric​ Parameters of Drugs/Contrast”.​

- Standard -​

Page 1498​

DICOM PS3.3 2020a - Information Object Definitions​

Attribute Name​

Tag​

Attribute Description​

Operator Identification Sequence​

(0008,1072)​

Person administering the substance to the patient, or legally​

 

 

responsible for the administration, and authorized to add an entry​

 

 

to the Medication Administration Record.​

 

 

One or more Items shall be included in this Sequence.​

>Person Identification Code​

(0040,1101)​

Coded identifier of the person administering the contrast agent,​

Sequence​

 

drug, or device.​

 

 

Only a single Item shall be included in this Sequence.​

>>Include Table 8.8-1 “Code Sequence Macro Attributes”​

No Baseline CID is defined.​

TheCodingSchemeDesignatorAttributemayindicatealocalcoding​ scheme (e.g., with value "L") when it is implicitly that of the​ institution's employee identifier system.​

The Code Meaning Attribute, though it is encoded with a VR of LO,​ may be encoded according to the rules of the PN VR (see​ Section 10.1).​

C.27 Common Surface IE Modules​

This section describes the specific Modules for the Surface IE.​

C.27.1 Surface Mesh Module​

Table C.27-1 specifies the Attributes of the Surface Mesh Module.​

Table C.27-1. Surface Mesh Module Attributes​

Attribute Name​

Tag​

Type​

Attribute Description​

Number of Surfaces​

(0066,0001)​

1​

Number of surfaces contained in the Instance. Shall be 1 or more.​

 

 

 

Shall be the same as the number of Items in Surface Sequence​

 

 

 

(0066,0002).​

Surface Sequence​

(0066,0002)​

1​

The surfaces that are described within the data.​

 

 

 

One or more Items shall be included in this Sequence.​

 

 

 

There shall be Number of Surfaces (0066,0001) Items in the​

 

 

 

Sequence.​

 

 

 

See Section C.27.1.1.1.​

>Surface Number​

(0066,0003)​

1​

Identification number of the surface. Uniquely identifies a surface​

 

 

 

within this SOP instance. Shall start at a value of 1, and increase​

 

 

 

monotonically by 1.​

>Surface Comments​

(0066,0004)​

3​

User-defined comments describing the surface.​

>Segmented Property​

(0062,0003)​

3​

Sequence defining the general category of the property the surface​

Category Code Sequence​

 

 

represents.​

 

 

 

Only a single Item is permitted in this Sequence.​

>>Include Table 8.8-1 “Code Sequence Macro Attributes”​

BCID 7150 “Segmentation Property Categories”.​

- Standard -​

 

DICOM PS3.3 2020a - Information Object Definitions​

Page 1499​

Attribute Name​

Tag​

Type​

Attribute Description​

 

>Segmented Property Type​

(0062,000F)​

3​

Sequence defining the specific property the surface represents.​

Code Sequence​

 

 

Note​

 

 

 

 

 

 

 

 

"Property"isusedinthesenseofmeaning"whatthesurface​

 

 

 

represents", whether it be a physical or biological object,​

 

 

 

be real or conceptual, having spatial, temporal or functional​

 

 

 

extent or not. I.e., it is what the segment "is" (as opposed​

 

 

 

to some feature, attribute, quality, or characteristic of it, like​

 

 

 

color or shape or size).​

 

 

 

Only a single Item is permitted in this Sequence.​

>>Include Table 8.8-1 “Code Sequence Macro Attributes”​

BCID 7151 “Segmentation Property Types”.​

>Surface Processing​

(0066,0009)​

2​

Specifies whether the surface has been modified subsequent to the​

 

 

 

original generation of the surface.​

 

 

 

Enumerated Values:​

 

 

 

YES​

 

 

 

NO​

 

 

 

See Section C.27.1.1.2.​

>Surface Processing Ratio​

(0066,000A)​

2C​

The Ratio of Remaining points to Original points after processing.​

 

 

 

Required if Surface Processing (0066,0009) is YES.​

>Surface Processing​

(0066,000B)​

3​

A textual description of the surface processing performed.​

Description​

 

 

 

>Surface Processing​

(0066,0035)​

2C​

Describes the processing method.​

Algorithm Identification​

 

 

Zero or one Item shall be included in this Sequence.​

Sequence​

 

 

Required if Surface Processing (0066,0009) is YES.​

>>IncludeTable10-19“AlgorithmIdentificationMacroAttributes”​For Algorithm Family Code Sequence (0066,002F) Baseline CID​ 7162 “Surface Processing Algorithm Families”.​

>Recommended Display​

(0062,000C)​

1​

A default single gray unsigned value in which it is recommended that​

Grayscale Value​

 

 

the maximum pixel value in this surface be rendered on a​

 

 

 

monochrome display. The units are specified in P-Values from a​

 

 

 

minimum of 0000H (black) up to a maximum of FFFFH (white).​

 

 

 

Note​

 

 

 

The maximum P-Value for this Attribute may be different​

 

 

 

from the maximum P-Value from the output of the​

 

 

 

Presentation LUT, which may be less than 16 bits in depth.​

>Recommended Display​

(0062,000D)​

1​

A default triplet value in which it is recommended that the surface be​

CIELab Value​

 

 

rendered on a color display. The units are specified in PCS-Values,​

 

 

 

and the value is encoded as CIELab.​

 

 

 

See Section C.10.7.1.1​

>Recommended​

(0066,000C)​

1​

Specifies the opacity in which it is recommended that the surface be​

Presentation Opacity​

 

 

rendered.​

 

 

 

See Section C.27.1.1.3.​

>Recommended​

(0066,000D)​

1​

Specifies the presentation type in which it is recommended that the​

Presentation Type​

 

 

surface be rendered.​

See Section C.27.1.1.3.​

- Standard -​

Page 1500​

DICOM PS3.3 2020a - Information Object Definitions​

Attribute Name​

Tag​

Type​

 

Attribute Description​

>Recommended Point​

(0066,0037)​

3​

Specifies the radius of the vertex points defined in the Long Vertex​

Radius​

 

 

Point Index List (0066,0043) with which it is recommended that the​

 

 

 

point be rendered.​

 

 

 

The units shall be the same as the units of the coordinate system in​

 

 

 

which the point coordinates are specified.​

>Recommended Line​

(0066,0038)​

3​

SpecifiesthethicknessofeachedgeorlinedefinedintheLongEdge​

Thickness​

 

 

Point Index List (0066,0042) or Line Sequence (0066,0028) with​

 

 

 

which it is recommended that the line be rendered.​

 

 

 

The units shall be the same as the units of the coordinate system in​

 

 

 

which the point coordinates are specified.​

>Finite Volume​

(0066,000E)​

1​

Indicates,whetherthesurfacerepresentsasolid("waterproof")object​

 

 

 

with an outside and an inside.​

 

 

 

Enumerated Values:​

 

 

 

YES​

Contains a finite volume​

 

 

 

NO​

Does not contain a finite volume​

 

 

 

UNKNOWN​Might or might not contain a finite volume​

 

 

 

See Section C.27.1.1.4.​

>Manifold​

(0066,0010)​

1​

Indicates whether the surface is describing an n-1 dimensional​

 

 

 

manifold in the underlying n-dimensional vector space.​

 

 

 

Enumerated Values:​

 

 

 

YES​

Manifold in every point​

 

 

 

NO​

Does contain non-manifold points​

 

 

 

UNKNOWN​Might or might not contain non-manifold points​

 

 

 

See Section C.27.1.1.5.​

>Surface Points Sequence​

(0066,0011)​

1​

The point positions representing vertices of the surface.​

 

 

 

Only a single Item shall be included in this Sequence.​

>>Include Table C.27-2 “Points Macro Attributes”​

 

 

 

>Surface Points Normals​

(0066,0012)​

2​

The normals on the surface for each point.​

Sequence​

 

 

Zero or one Item shall be included in this Sequence.​

 

 

 

 

 

 

See Section C.27.1.1.6.​

>>Include Table C.27-3 “Vectors Macro Attributes”​

 

NumberofVectors(0066,001E)shallequalNumberofSurfacePoints​

 

 

 

(0066,0015) in this Surface Sequence (0066,0002) Item.​

 

 

 

Vector Dimensionality (0066,001F) shall be 3.​

 

 

 

IfFiniteVolume(0066,000E)isYES,thenormalsoftheverticesshall​

 

 

 

point toward the outside of the object. If Finite Volume (0066,000E)​

 

 

 

is not YES, the direction of the normals shall be consistent where​

 

 

 

possible.​

 

>Surface Mesh Primitives​

(0066,0013)​

1​

Only a single Item shall be included in this Sequence.​

Sequence​

 

 

 

 

>>Include Table C.27-4 “Surface Mesh Primitives Macro​ Attributes”​

The primitives' indices shall not exceed Number of Surface Points​ (0066,0015) in this Surface Sequence (0066,0002) Item.​

- Standard -​